Impact of BNP on cryptogenic stroke without potential embolic sources on transesophageal echocardiography

J Neurol Sci. 2015 Dec 15;359(1-2):287-92. doi: 10.1016/j.jns.2015.11.014. Epub 2015 Nov 11.

Abstract

Background: Clinical characteristics are important for determining the etiologies of embolic stroke, including patent foramen ovale and complex aortic plaques demonstrated on transesophageal echocardiography (TEE). This study sought to analyze the clinical signs of cryptogenic stroke (CS) without such embolic etiologies and to examine the association between CS and brain natriuretic peptide (BNP), which is currently unknown.

Methods: Patients with CS after routine examinations who underwent TEE were included in this single-center observational study. Patients were classified into the potential embolic sources (PES) group (patients having PES on TEE) and the no potential embolic source (NPES) group. Patients were also categorized according to the tertile of BNP.

Results: A total of 158 patients (age, 64.0 ± 13.9 years; 119 males) with CS were enrolled. The PES group had 108 (68%) patients, and the NPES group had 50 (32%). Hypertension was more common, and glucose, D-dimer, and BNP were higher in the NPES than in the PES group (p<0.05). NPES was independently associated with high-BNP tertile (OR: 5.61; 95% CI: 1.91 to 16.44; p=0.002).

Conclusions: BNP, an indicator of cardioembolism, was closely associated with NPES. Cardiogenic mechanisms may be implicated in the etiology of CS without potential embolic etiologies on TEE.

Keywords: Brain natriuretic peptide; Cryptogenic stroke; Stroke; TOAST classification; Transesophageal echocardiography.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Echocardiography, Transesophageal*
  • Embolism / etiology*
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Natriuretic Peptide, Brain / blood*
  • Risk Factors
  • Statistics, Nonparametric
  • Stroke / blood*
  • Stroke / diagnostic imaging*

Substances

  • Natriuretic Peptide, Brain